首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Antineoplastics/antirheumatics/mesalazineLack of efficacy: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2022年
/ 1890卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-022-09042-z
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:45 / 45
相关论文
共 50 条
[1]
Antineoplastics/antirheumatics/mesalazineHypersensitivity reaction, status epilepticus and lack of efficacy: case report
[J].
Reactions Weekly,
2022,
1930
(1)
: 77
-
77
[2]
MesalazineLack of efficacy: case report
[J].
Reactions Weekly,
2023,
1959
(1)
: 394
-
394
[3]
MesalazineLack of efficacy: case report
[J].
Reactions Weekly,
2023,
1959
(1)
: 395
-
395
[4]
MesalazineLack of efficacy: case report
[J].
Reactions Weekly,
2023,
1952
(1)
: 218
-
218
[5]
Glutamine/mesalazineLack of efficacy: case report
[J].
Reactions Weekly,
2023,
1938
(1)
: 659
-
659
[6]
MesalazineLack of efficacy: case report
[J].
Reactions Weekly,
2021,
1885
(1)
: 312
-
312
[7]
MesalazineLack of efficacy: case report
[J].
Reactions Weekly,
2023,
1986
(1)
: 251
-
251
[8]
MesalazineLack of efficacy: case report
[J].
Reactions Weekly,
2023,
1948
(1)
: 266
-
266
[9]
MesalazineLack of efficacy: case report
[J].
Reactions Weekly,
2021,
1871
(1)
: 245
-
245
[10]
Budesonide/mesalazineLack of efficacy: case report
[J].
Reactions Weekly,
2021,
1836
(1)
: 191
-
191
←
1
2
3
4
5
→